etoposide has been researched along with adenosine diphosphate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lindsley, JE; Morris, SK | 1 |
Brusa, D; Coscia, M; D'Arena, G; Deaglio, S; Gaidano, G; Horenstein, AL; Inghirami, G; Laurenti, L; Malavasi, F; Robson, SC; Rossi, D; Serra, S; Tripodo, C; Vaisitti, T | 1 |
2 other study(ies) available for etoposide and adenosine diphosphate
Article | Year |
---|---|
Yeast topoisomerase II is inhibited by etoposide after hydrolyzing the first ATP and before releasing the second ADP.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Amino Acid Substitution; DNA Topoisomerases, Type II; Etoposide; Hydrolysis; Kinetics; Models, Chemical; Mutagenesis, Site-Directed; Plasmids; Recombinant Proteins; Saccharomyces cerevisiae; Topoisomerase II Inhibitors | 1999 |
CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Antigens, CD; Antineoplastic Agents, Phytogenic; Apyrase; Autocrine Communication; Cell Death; Cell Differentiation; Cell Movement; Cell Survival; Etoposide; Extracellular Space; GPI-Linked Proteins; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Paracrine Communication; Receptor, Adenosine A2A; Tumor Cells, Cultured | 2011 |